WELLGISTICS HEALTH INC
WGRXNASDAQTrading Snapshot
- Day Range
- $3.51 – $3.54
- 52-Week Range
- $2.49 – $97.50
- Volume
- $1.69B
- Avg Volume
- $1.55B
- Shares Outstanding
- 2.5M
- Next Earnings
- Nov 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $23M
- Last Q Revenue
- $2M
- P/E Ratio
- -0.1
- P/S Ratio
- 1.1x
- EPS (TTM)
- $-34.29
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +36.7%
Why Investors Own WGRX
- ✓High-growth profile — revenue up +14.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 64% gross margin and 6% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
WELLGISTICS HEALTH INC
WGRX
StockOtter · stockotter.spaceAbout WELLGISTICS HEALTH INC
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS,
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data TAMPA, Fla., July 21, 2026 /PRNewswire/ -- Wellgistics Health, Inc.,
Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
TAMPA, FL / ACCESS Newswire / July 20, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription drug routing into
Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.
Rubenstein PR named AOR for Wellgistics Health (WGRX) to launch its AI Healthcare ecosystem, expanding EinsteinRx & PharmacyChain for advanced Health IT.
Wellgistics Health Appoints Brett Thompson as Chief Technology Officer
Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company TAMPA, FL / ACCESS Newswire / July 15, 2026 / Wellgistics Health, Inc. (the "Company" or "Wellgistics") (NASDAQ:WGRX), a He
Wellgistics Health Executive Chairman and President Exercise Warrants
Executives exercise previously issued warrants to acquire 200,000 common shares Shares issued in connection with exercise added to existing lock-up agreements TAMPA, FL / ACCESS Newswire / June 30, 2026 / Wellgistics Hea